Status: current, Defined. Date: 31-Dec 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2951671000168115 | Irinotecan Hydrochloride Trihydrate (Kabi) (irinotecan hydrochloride trihydrate 300 mg / 15 mL) injection, 1 x 15 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2951681000168117 | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | has TP | Irinotecan Hydrochloride Trihydrate (Kabi) | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Is a | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | has TPUU | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR